Helen Ambrose

Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment

Eminy H.Y. Lee, S RYAN, Bruce K. Birmingham et al. · Clinical Pharmacology & Therapeutics · 2005 · 473 citations

AKT Inhibition in Solid Tumors With <i>AKT1</i> Mutations

David M. Hyman, Lillian M. Smyth, Mark T.A. Donoghue et al. · Journal of Clinical Oncology · 2017 · 315 citations · Full text

A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in <i>PIK3CA</i> -Mutated Breast and Gynecologic Cancers

Udai Banerji, Emma Dean, José Alejandro Pérez Fidalgo et al. · Clinical Cancer Research · 2017 · 139 citations · Full text

Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey

Jonathan P. Clewley, Catherine M. Kelly, Nick Andrews et al. · BMJ · 2009 · 106 citations · Full text

Biomarker-Directed Phase II Platform Study in Patients With EGFR Sensitizing Mutation-Positive Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy (ORCHARD)

Helena A. Yu, Sarah B. Goldberg, Xiuning Le et al. · Clinical Lung Cancer · 2021 · 65 citations · Full text

Oncology, Medicine, Metronomic Therapy +11